STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype

Leuk Res. 2019 Mar:78:21-23. doi: 10.1016/j.leukres.2019.01.004. Epub 2019 Jan 15.

Authors

G Ciangola¹, C Gurnari¹, G Paterno¹, M Mirabile², M Angelini³, S Lavorgna¹, T Ottone¹, S Travaglini¹, L Cicconi¹, F LoCoco⁴

Affiliations

¹ Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
² Hematology Unit, Ospedale di Civitanova Marche ASUR AV3, Italy.
³ Hematology Unit, Ospedale C.G. Mazzoni, Ascoli Piceno, Italy.
⁴ Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy. Electronic address: [email protected].

PMID: 30665050
DOI: 10.1016/j.leukres.2019.01.004

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Hematopoietic Stem Cell Transplantation / methods
Humans
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Oncogene Proteins, Fusion / genetics*
STAT5 Transcription Factor / genetics*

Substances

Oncogene Proteins, Fusion
STAT5 Transcription Factor
STAT5-RARalpha protein, human